Provention Bio Inc (PRVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | PRVB | PTGX | RCKT | ||
Company | Provention Bio Inc | Protagonist Therapeutics Inc | Rocket Pharmaceuticals Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 24.99 | 41.99 | 26.45 | ||
High | 25.00 | 41.99 | 26.98 | ||
Low | 24.98 | 40.07 | 25.33 | ||
Last | 24.98 | 40.28 | 25.33 | ||
Change | +0.75 | -1.29 | -0.55 | ||
% Change | +3.10% | -3.10% | -2.13% | ||
Volume | 9,124,100 | 770,100 | 821,100 | ||
20-Day Average Volume | 2,505,925 | 1,581,350 | 895,285 | ||
Previous Close | 24.23 | 41.57 | 25.88 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 24.34 | 36.42 | 22.51 | ||
20-Day Raw Stochastic | 98.15% | 74.74% | 80.31% | ||
20-Day Relative Strength | 79.66% | 65.78% | 61.53% | ||
Weighted Alpha | +19.60 | +124.56 | +14.58 | ||
Today's Opinion | 100% Buy | 100% Buy | 8% Sell | ||
Previous Opinion | 88% Buy | 100% Buy | 8% Buy | ||
Last Month's Opinion | 100% Buy | 88% Buy | 72% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +2.21% since 04/19/23 | +13.31% since 07/19/24 | +11.00% since 07/19/24 | ||
Low | 24.20 on 04/25/23 | 35.44 on 07/23/24 | 22.80 on 07/22/24 | ||
High | 25.00 on 04/26/23 | 42.67 on 07/25/24 | 26.98 on 07/26/24 | ||
1-Month | |||||
%Chg | +4.56% since 03/24/23 | +26.83% since 06/26/24 | +18.98% since 06/26/24 | ||
Low | 23.82 on 03/27/23 | 31.34 on 06/27/24 | 18.60 on 06/28/24 | ||
High | 25.00 on 04/26/23 | 42.67 on 07/25/24 | 26.98 on 07/26/24 | ||
3-Month | |||||
%Chg | +186.80% since 01/26/23 | +60.16% since 04/26/24 | +15.24% since 04/26/24 | ||
Low | 6.59 on 03/10/23 | 24.78 on 05/01/24 | 18.60 on 06/28/24 | ||
High | 25.00 on 04/26/23 | 42.67 on 07/25/24 | 26.98 on 07/26/24 | ||
6-Month | |||||
%Chg | +279.64% since 10/26/22 | +61.57% since 01/26/24 | -10.34% since 01/26/24 | ||
Low | 6.38 on 10/28/22 | 24.22 on 04/26/24 | 18.60 on 06/28/24 | ||
High | 25.00 on 04/26/23 | 42.67 on 07/25/24 | 31.47 on 02/27/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 2,367,629 | 2,438,164 | 2,349,438 | ||
Shares Outstanding, K | 94,781 | 58,652 | 90,782 | ||
Annual Sales | 12,900,000 | 60,000,000 | 0 | ||
Annual Net Income | -113,570,000 | -78,960,000 | -245,600,000 | ||
Last Quarter Sales | 10,810,000 | 254,950,000 | 0 | ||
Last Quarter Net Income | -33,280,000 | 207,340,000 | -62,050,000 | ||
60-Month Beta | 2.47 | 2.13 | 1.13 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.38 on 03/29/23 | 3.26 on 05/07/24 | -0.66 on 05/06/24 | ||
Latest Earnings Date | 05/04/23 | 08/01/24 | 08/08/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 17.17 | 0.00 |